Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-47.50	40.44	77.02
Graham Fair Price	28.65	21.82	16.96
PEG	-94.58	-0.09	1.67
Price/Book	21.06	1.63	1.35
Price/Cash Flow	82.47	-14.65	8.03
Prices/Earnings	-27.69	24.10	-33.34
Price/Sales	-1.18	8.99	9.10
Price/FCF	82.47	-14.65	8.03
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	12.31	0.41	0.36
Operating Margin	403.80	0.17	0.03
ROA	63.22	< 0.005	< 0.005
ROE	-0.01	0.02	67.42
ROIC	< 0.005	0.02	523.32
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.86	-0.58	49.50
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	1.39	5.10	266.29
EPS QOQ	0.20	2.67	1233.33
FCF QOQ	16.73	-1.66	-90.10
Revenue QOQ	0.43	0.21	-50.90
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	262.43	208.65	-20.49
Days Sales Outstanding (DSO)	133.24	158.96	19.31
Inventory Turnover	0.34	0.43	25.78
Debt/Capitalization	0.09	0.16	74.46
Quick Ratio	0.79	0.89	12.74
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	35.56	35.36	-0.57
Cash	3.89	3.09	-20.56
Capex	-0.26	-0.21	18.71
Free Cash Flow	5.97	-3.94	-34.04
Revenue	5.27	6.41	21.80
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.56	1.51	-3.04
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.36	2.47	594.24
Naive Interpretation	Member

06 - Financial Health · Weak

Rating